Verrica Pharmaceuticals Inc (VRCA) — Financial Flexibility Index
Verrica Pharmaceuticals Inc (VRCA) has a Financial Flexibility Index of -0.21x as of December 2025. Free cash flow of $-4.59 Million (operating CF $-4.59 Million minus capex $0.00) represents 0% of total liabilities ($22.39 Million). Also explore Verrica Pharmaceuticals Inc (VRCA) net asset momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Verrica Pharmaceuticals Inc Financial Flexibility Index (2016–2025)
Historical Financial Flexibility Index trend for Verrica Pharmaceuticals Inc across 10 annual periods. Check VRCA capital-intensive asset ratio to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Verrica Pharmaceuticals Inc (2016–2025)
Year-by-year free cash flow to debt coverage for Verrica Pharmaceuticals Inc. For the full company profile including market capitalisation, see Verrica Pharmaceuticals Inc market capitalisation.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.79x | $-17.63 Million | $-17.63 Million | $22.39 Million | ▲ +17.3% |
| 2024 | -0.95x | $-60.90 Million | $-60.93 Million | $63.99 Million | ▼ -54.0% |
| 2023 | -0.62x | $-38.22 Million | $-38.58 Million | $61.83 Million | ▲ +84.2% |
| 2022 | -3.91x | $-18.35 Million | $-18.65 Million | $4.69 Million | ▼ -596.6% |
| 2021 | -0.56x | $-26.70 Million | $-27.58 Million | $47.52 Million | ▲ +19.5% |
| 2020 | -0.70x | $-28.74 Million | $-30.21 Million | $41.17 Million | ▲ +91.1% |
| 2019 | -7.84x | $-26.73 Million | $-27.41 Million | $3.41 Million | ▼ -13.6% |
| 2018 | -6.90x | $-17.10 Million | $-17.87 Million | $2.48 Million | ▼ -2822.3% |
| 2017 | -0.24x | $-3.81 Million | $-4.58 Million | $16.12 Million | ▲ +9.5% |
| 2016 | -0.26x | $-837.00K | $-1.61 Million | $3.21 Million | — |